DC Funds, LP TCRX Holdings History

Number of Shares
630,000.00
Current Holdings Value*
$869,400.00
% of Portfolio
42.07%
Total Estimate Gain
$-4.69 Mil
% of Total Estimate Gain
-80.45%

DC Funds, LP's TScan Therapeutics Inc Holding Summary

As of 2025-03-31, DC Funds, LP held 630,000.00 shares of TScan Therapeutics Inc(TCRX), totaling $869,400.00. This investment constitutes 42.07% of their stock portfolio, and DC Funds, LP now holds 1.11% of the outstanding TScan Therapeutics Inc(TCRX) stock.

The initial trade took place in 2021Q3. And since then DC Funds, LP has made 1 purchases of TCRX, at an average price of $9.26, for a total of 630,000.00 shares. Based on historical transaction data and TCRX's current price of $1.81, DC Funds, LP's estimated gain on his TCRX holdings is $-4.69 Mil, reflecting a -80.45% gain to date.

DC Funds, LP TCRX ($1.81) Holding Chart

DC Funds, LP TCRX ($1.81) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1